Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy

Published:2011 Issue:1 Volume:81 Page:30-38
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Keskin Serkan,Muslumanoglu Mahmut,Saip Pinar,Karanlık Hasan,Guveli Murat,Pehlivan Esmehan,Aydoğan Fatma,Eralp Yesim,Aydıner Adnan,Yavuz Ekrem,Ozmen Vahit,Igci Abdullah,Topuz Erkan

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference37 articles.

1. Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features

2. Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

3. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer

4. Long-Term Outcomes in Stage IIIB Breast Cancer Patients Who Achieved Less Than a Pathological Complete Response (<pCR) After Primary Chemotherapy

5. Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Study of Peripheral Blood Inflammatory Indicators in Triple-Negative Breast Cancer after Neoadjuvant Chemotherapy;Advances in Clinical Medicine;2023

2. Comparison of progressed and unresponsive patients with responsive patients at ınterim assessment during breast cancer neoadjuvant chemotherapy;Ege Tıp Dergisi;2022-09-12

3. Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis;The Breast;2022-02

4. Evaluation of Clinical and Pathological Response in Breast Cancer Following Neoadjuvant Chemotherapy- A Single Institution Experience;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2022

5. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer;European Radiology;2021-11-12